Reckon Pharmachem Private Limited, a struck off private limited company, was established on 18 October 2001 in New Delhi, Delhi, India. Engaging in api manufacturers within the pharma sector, it holds CIN: U24231DL2001PTC186327. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹10.00 Cr.
Formerly known as Nb Welcome Chemicals Private Limited. It upholds a active non-compliant status. Its leadership includes Mohanan Karunakaran (Director), Vimal Aggarwal (Director). Past directors included Viniti Agarwal, Jai Parkash Agarwal, Sandeip Agarrwal. It holds no open charges and ₹18.85 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-562, New Friends Colony, New Delhi, Delhi, 110025.
U24231DL2001PTC186327
186327
18 October 2001
₹10.00 Cr
₹10.00 Cr
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Reckon Pharmachem Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohanan Karunakaran | Director | 15 Dec 2018 | Current |
| Vimal Aggarwal | Director | 01 Jul 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Dec 2008 | Past |
| Pramod Abcsdd | Additional Director | 01 Jul 2016 | Past |
| Pramod Abcsdd | Director | 15 Dec 2018 | Past |
| Pramod Abcsdd | Additional Director | 04 Jan 2019 | Past |
| Pramod Abcsdd | Director | 10 May 2016 | Past |
| Pramod Abcsdd | Director | 09 Oct 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reckon Pharmachem Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 665.93% increase in profit. The company's net worth moved up by a moderate rise of 3.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Reckon Pharmachem had a promoter holding of 94.45% and a public holding of 5.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹188,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2004 | State Bank Of India | ₹18.85 Cr | Satisfied |
Explore comprehensive loan charge details -
Reckon Pharmachem has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Reckon Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reckon Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Happy Jaju was appointed as a Company Secretary was appointed as a Company Secretary on 10 Dec 2024 & has been associated with this company since 11 months 23 days . was recorded as a recent event.
Reckon Pharmachem Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Reckon Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Mohanan Karunakaran was appointed as a Director was appointed as a Director on 15 Dec 2018 & has been associated with this company since 6 years 11 months . was documented.
The activity Vimal Aggarwal was appointed as a Director was appointed as a Director on 01 Jul 2016 & has been associated with this company since 9 years 5 months . was completed.
A charge registered on 23 Jul 2004 via Charge ID 90148802 with State Bank Of India was fully satisfied on 07 Dec 2015. was recorded as a recent event.
The CIN of Reckon Pharmachem Private Limited is U24231DL2001PTC186327.
Reckon Pharmachem Private Limited is headquartered at C-562, New Friends Colony, New Delhi, Delhi, 110025.
Reckon Pharmachem Private Limited was incorporated on 18 October 2001.
The current directors of Reckon Pharmachem Private Limited are
The primary industry of Reckon Pharmachem Private Limited is Pharma.
Reckon Pharmachem Private Limited is unlisted.
The authorized capital of Reckon Pharmachem Private Limited is ₹10.00 Cr, and the paid-up capital is ₹10.00 Cr.
The compliance status of Reckon Pharmachem Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX